文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

相对高血糖是危重患者院内死亡的独立决定因素

Relative Hyperglycemia Is an Independent Determinant of In-Hospital Mortality in Patients With Critical Illness.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论在危重患者中,应激性高血糖比值(相对高血糖)独立预测院内死亡,而入院血糖绝对值经死亡风险评分校正后无此关联。

这项前瞻性观察研究纳入2016年1月27日至2017年3月30日期间某大城市教学医院混合内外科ICU的1262例连续患者,用糖化血红蛋白估算既往3个月平均血糖,入院血糖除以估算平均血糖得应激性高血糖比值。院内死亡186例(14.7%)。入院血糖单变量分析与死亡显著相关(每升高1 mmol/L,OR=1.08,P<0.001),但校正死亡风险评分后不再显著(OR=1.01,P=0.338);应激性高血糖比值单变量(每增加0.1,OR=1.09,P<0.001)及校正后(OR=1.03,P=0.014)均与死亡显著相关。在糖化血红蛋白<6.5%和≥6.5%(48 mmol/mol)亚组中,应激性高血糖比值均与死亡显著相关(每增加0.1,OR均为1.08,P分别<0.001和=0.005)。

要点

  • 应激性高血糖比值(入院血糖/糖化血红蛋白估算的平均血糖)每增加0.1,院内死亡风险独立升高(校正死亡风险评分后OR=1.03,P=0.014)。
  • 入院血糖绝对值每升高1 mmol/L,单变量分析与死亡相关(OR=1.08,P<0.001),但校正死亡风险评分后不再显著(OR=1.01,P=0.338)。
  • 在糖化血红蛋白<6.5%和≥6.5%(48 mmol/mol)的患者中,应激性高血糖比值每增加0.1,死亡OR均为1.08(P分别<0.001和=0.005)。
  • 该研究为单中心前瞻性观察研究,共纳入1262例连续ICU患者,院内死亡186例(14.7%)。

适用人群与场景

  • 某大城市教学医院混合内外科ICU的连续成人患者,2016年1月27日至2017年3月30日期间收治,符合纳入和排除标准者共1262例。

诊断标准与关键阈值

  • 应激性高血糖比值 = 入ICU时血糖浓度 / 糖化血红蛋白估算的既往3个月平均血糖浓度。
  • 糖化血红蛋白用于估算既往3个月平均血糖浓度。
  • 死亡风险评分采用提交至澳大利亚和新西兰重症监护学会的数据计算。

研究设计与关键结果

  • 研究类型为前瞻性观察研究,单中心,纳入1262例连续ICU患者,院内死亡186例(14.7%)。
  • 入院血糖单变量分析:每升高1 mmol/L,OR=1.08(P<0.001);校正死亡风险评分后OR=1.01(P=0.338),未达统计学显著。
  • 应激性高血糖比值单变量分析:每增加0.1,OR=1.09(P<0.001);校正死亡风险评分后OR=1.03(P=0.014)。
  • 糖化血红蛋白<6.5%亚组:应激性高血糖比值每增加0.1,OR=1.08(P<0.001)。
  • 糖化血红蛋白≥6.5%(48 mmol/mol)亚组:应激性高血糖比值每增加0.1,OR=1.08(P=0.005)。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与绝对高血糖不同,应激性高血糖比值所评估的相对高血糖可独立预测危重患者院内死亡,且不受基础血糖水平影响。
  • 作者建议,未来研究应探讨使用相对高血糖指标确定个体化血糖治疗目标是否改善ICU结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine whether relative hyperglycemia was associated with in-hospital mortality in critically ill patients independent of other prognostic variables and whether this association is affected by background glycemia.

DESIGN: Prospective observational study.

SETTING: Mixed medical-surgical ICU in a metropolitan teaching hospital.

PATIENTS: From 2,617 admissions to ICU between January 27, 2016, and March 30, 2017, 1,262 consecutive patients who met inclusion and exclusion criteria were studied.

INTERVENTIONS: Glycosylated hemoglobin was used to estimate average glucose concentration over the prior 3 months. Glucose concentration on ICU admission was divided by estimated average glucose concentration to calculate the stress hyperglycemia ratio, an index of relative glycemia. Risk of death score was calculated using data submitted to the Australia and New Zealand Intensive Care Society.

MEASUREMENTS AND MAIN RESULTS: In this study, there were 186 deaths (14.7%). Admission glucose was significantly associated with mortality in univariate analysis (odds ratio = 1.08 per mmol/L glucose increment; p < 0.001) but not after adjustment for risk of death score (odds ratio = 1.01; p = 0.338). In contrast, stress hyperglycemia ratio was significantly associated with mortality both in univariate analysis (odds ratio = 1.09 per 0.1 stress hyperglycemia ratio increment; p < 0.001) and after adjustment for risk of death score (odds ratio = 1.03; p = 0.014). Unlike admission glucose concentration, stress hyperglycemia ratio was significantly associated with mortality in patients with glycosylated hemoglobin less than 6.5% (odds ratio = 1.08 per 0.1 stress hyperglycemia ratio increment; p < 0.001) and glycosylated hemoglobin greater than or equal to 6.5% (48 mmol/mol) (odds ratio = 1.08 per 0.1 stress hyperglycemia ratio increment; p = 0.005).

CONCLUSIONS: Unlike absolute hyperglycemia, relative hyperglycemia, as assessed by the stress hyperglycemia ratio, independently predicts in-hospital mortality in critically ill patients across the glycemic spectrum. Future studies should investigate whether using measures of relative hyperglycemia to determine individualized glycemic treatment targets improves outcomes in ICU.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lee TF, Drake SM, Roberts GW, et al. Relative Hyperglycemia Is an Independent Determinant of In-Hospital Mortality in Patients With Critical Illness. Crit Care Med. 2020. PMID: 31939810. doi:10.1097/CCM.0000000000004133

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。